Immunological investigations in experimental chemotherapy. 3. The initial period of low resistance in bacterial infections of mice in relation to bacteriostatic chemotherapy.
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D002751:Chlortetracycline / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000276:immunology; D007239:Infections / Q000188:drug therapy* / Q000276:immunology*; D007710:Klebsiella Infections / Q000188:drug therapy / Q000276:immunology; D008088:Listeriosis / Q000188:drug therapy / Q000276:immunology; D051379:Mice; D010326:Pasteurella Infections / Q000188:drug therapy / Q000276:immunology; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000276:immunology; D011512:Proteus Infections / Q000188:drug therapy / Q000276:immunology; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000276:immunology; D012480:Salmonella Infections / Q000188:drug therapy; D012481:Salmonella Infections, Animal / Q000276:immunology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000276:immunology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000276:immunology; D013420:Sulfamethoxazole / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D013997:Time Factors
D062365:Aminobenzoates; D013449:Sulfonamides; D013420:Sulfamethoxazole; D002751:Chlortetracycline